Senior Health Economist

Boehringer Ingelheim Pharmaceuticals, Inc; Bracknell; On-site; GBP 60,000 - 90,000; Full time

Job summary

An established industry player is seeking a Senior Health Economist to drive value creation and communication for its product portfolio. This role involves leading National Market Access Plans, designing HTA strategies, and ensuring that health economic approaches align with business objectives. The successful candidate will collaborate with cross-functional teams and manage projects with third-party vendors, all while fostering the development of in-house Health Economists. If you're passionate about improving patient access and making a significant impact in the healthcare landscape, this is the opportunity for you.

Qualifications

• MSc in Health Economics or equivalent discipline required.
• Experience with HTA bodies like NICE and SMC is essential.

Responsibilities

• Lead development of National Market Access Plans for allocated products.
• Design HTA strategy and manage HTA processes for UK/Ireland.
• Integrate payer insights into health economic strategies.

Skills

Health Economics

HTA Strategy

Economic Evaluation

Cross-functional Collaboration

Value Communication

Education

MSc in Health Economics

Equivalent Discipline

Job description

This job is brought to you by Jobs/Redefined, the UK's leading over-50s age inclusive jobs board.

THE POSITION

The Senior Health Economist is responsible for value creation and demonstration, effectively communicating the value of an allocated product portfolio to national payers and related stakeholders, thereby removing barriers to patient access, via a proactive in-house approach to Health Economics.

Tasks & responsibilities

• Leads the development, review and refinement of UK/Ireland National Market Access Plans for Boehringer Ingelheim products in collaboration with various internal stakeholders
• Designs and develops optimal HTA strategy and leads all aspects of the HTA process for allocated products in UK/Ireland, to optimise HTA conditions for pipeline assets and minimise value erosion within inline brands
• Demonstrates HE functional excellence behaviours by leading and adapting (where appropriate) Corporate HEOR materials to ensure they are fit-for-purpose to the UK/Ireland setting and comply with ABPI Code of Practice. Commissions and manages large projects with third-party vendors and both internal and external stakeholders.
• Fosters the in-house development and training of other Boehringer Ingelheim Health Economists
• Takes a prominent role in cross-functional Franchise teams and is a recognized authority, ensuring that Market Access is integral to brand strategy and tactics
• Provides timely and accurate delivery of horizon scanning information on pipeline products. Ensures Market Access input during early-stage product development and assessment
• Leads the integration and validation of payer insights into the health economic approach and deliverables (HTA and payer value proposition). Translate patient access strategy into robust health economic strategies and Boehringer Ingelheim studies. Proactively communicate actionable conclusions, recommendations, and payer value messages.

Requirements

• At least an MSc in Health Economics or equivalent discipline
• Good working knowledge and practical experience of all methods of economic evaluation, the requirements, and processes of HTA bodies including NICE and SMC
• In depth technical knowledge of HE modelling and value communication & implementation using a variety of channels
• Ability to apply these approaches to support Boehringer Ingelheim's business objectives
• Ability to collaborate and communicate with cross-functional teams, and to work at a strategic level within cross-functional teams
• Experience of working within ABPI and IPHA codes of practice would be advantageous